Amitriptyline blocks innate immune responses mediated by toll‐like receptor 4 and IL‐1 receptor: Preclinical and clinical evidence in osteoarthritis and gout-Reference-Cited by-同舟云学术

Amitriptyline blocks innate immune responses mediated by toll‐like receptor 4 and IL‐1 receptor: Preclinical and clinical evidence in osteoarthritis and gout

Published:2021-12-12 Issue:2 Volume:179 Page:270-286
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British J Pharmacology

Author:

Franco‐Trepat Eloi¹^ORCID,Alonso‐Pérez Ana¹^ORCID,Guillán‐Fresco María¹^ORCID,Jorge‐Mora Alberto¹^ORCID,Crespo‐Golmar Antia¹^ORCID,López‐Fagúndez Miriam¹^ORCID,Pazos‐Pérez Andrés¹^ORCID,Gualillo Oreste²^ORCID,Belén Bravo Susana³^ORCID,Gómez Bahamonde Rodolfo¹^ORCID

Affiliation:

1. Musculoskeletal Pathology Group, Institute IDIS, SERGAS Santiago University Clinical Hospital (CHUS) Santiago de Compostela Spain

2. NEIRID LAB, Institute IDIS, SERGAS Santiago University Clinical Hospital (CHUS) Santiago de Compostela Spain

3. Proteomics Unit, Institute IDIS Santiago University Clinical Hospital (CHUS) Santiago de Compostela Spain

Funder

Fundación Mutua Madrileña

Instituto de Investigación Sanitaria de Santiago de Compostela

Ministerio de Ciencia e Innovación

European Regional Development Fund

Instituto de Salud Carlos III

Publisher

Wiley